NON-INVASIVE FETAL RHD GENOTYPING OF RHD NEGATIVE PREGNANT WOMEN FOR TARGETED ANTI-D THERAPY IN AUSTRALIA: A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Gordon, L. [1 ]
Flower, R. [2 ]
Hyland, C. [2 ]
机构：
[1] IQIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Australian Red Cross Blood Serv, Brisbane, Qld, Australia
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.700
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND4
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [21] Non-invasive fetal RhD genotyping and first trimester screen clinical implications for the management of RhD-negative mother
    Holtzman, Eliezer
    Geifman-Holtzman, Ossie
    Jeronis, Stacey
    Xiong, Yali
    Liebermann, Dan
    Hoffman, Barbara
    Prabhakaran, Indhu
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S290 - S290
  • [22] Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice
    Kent, Julie
    Farrell, Anne-Maree
    Soothill, Peter
    BMC PREGNANCY AND CHILDBIRTH, 2014, 14
  • [23] Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review
    Trina M Fyfe
    M Jane Ritchey
    Christorina Taruc
    Daniel Crompton
    Brian Galliford
    Rose Perrin
    BMC Pregnancy and Childbirth, 14
  • [24] Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types
    Hyland, Catherine A.
    Millard, Glenda M.
    O'Brien, Helen
    Schoeman, Elizna M.
    Lopez, Genghis H.
    McGowan, Eunike C.
    Tremellen, Anne
    Puddephatt, Rachel
    Gaerty, Kirsten
    Flower, Robert L.
    Hyett, Jonathan A.
    Gardener, Glenn J.
    PATHOLOGY, 2017, 49 (07) : 757 - 764
  • [25] Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review
    Fyfe, Trina M.
    Ritchey, M. Jane
    Taruc, Christorina
    Crompton, Daniel
    Galliford, Brian
    Perrin, Rose
    BMC PREGNANCY AND CHILDBIRTH, 2014, 14
  • [26] Resource Utilization after First Trimester Noninvasive Fetal RHD Screening for Targeted Antenatal Anti-D Prophylaxis in RhD-Negative Swedish Women
    Neovius, M.
    Tiblad, E.
    Westgren, M.
    Neovius, K.
    Wikman, A. T.
    TRANSFUSION, 2014, 54 : 18A - 19A
  • [27] High Reliability of Non-invasive Prenatal Assessment of Fetal RHD Using Two Independent Blood Samples from RhD Negative Pregnant Women
    Hyland, C. A.
    Gardener, G. J.
    Hyett, J. A.
    Davies, H.
    Millard, G.
    Morris, J.
    Ward, C. M.
    Flower, R. L.
    TRANSFUSION, 2009, 49 : 133A - 133A
  • [28] The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti-D prophylaxis
    Sorensen, Kirsten
    Baevre, Mette S.
    Tomter, Geir
    Llohn, Abid Hussain
    Hagen, Kristin G.
    Espinosa, Aurora
    Jacobsen, Barbora
    Arsenovic, Mirajana Grujic
    Sorvoll, Ingvild Hausberg
    Ulvahaug, Aud Norunn
    Sundic, Tatjana
    Akkok, Cigdem Akalin
    TRANSFUSION MEDICINE, 2021, 31 (05) : 314 - 321
  • [29] Non-invasive fetal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative Brazilian pregnant women
    Chinen, P. A.
    Nardozzaa, L. M. M.
    Camano, L.
    Moron, A. F.
    Pares, D. B. S.
    Martinhago, C. D.
    Daher, S.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2007, 75 (01) : A8 - A9
  • [30] INTRODUCTION OF AN RHD NEGATIVE TYPE-AND-SCREEN IN PREGNANT WOMEN TREATED WITH ANTI-D PROPHYLAXIS
    Gustafsson, L. W.
    Dara, S.
    Taune-Wikman, A.
    Auvinen, M. K.
    VOX SANGUINIS, 2013, 105 : 246 - 246
12345